1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Low-Grade Glioma Global Clinical Trials Review, H1, 2014

Low-Grade Glioma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Low-Grade Glioma Global Clinical Trials Review, H1, 2014" provides data on the Low-Grade Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Low-Grade Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Low-Grade Glioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Low-Grade Glioma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Low-Grade Glioma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Low-Grade Glioma to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Low-Grade Glioma to Oncology Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Low-Grade Glioma 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Low-Grade Glioma Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Stemline Therapeutics, Inc. 28
Clinical Trial Overview of Stemline Therapeutics, Inc. 28
AROG Pharmaceuticals LLC 29
Clinical Trial Overview of AROG Pharmaceuticals LLC 29
Clinical Trial Overview of Top Institutes / Government 30
National Cancer Institute 30
Clinical Trial Overview of National Cancer Institute 30
University of California, San Francisco 31
Clinical Trial Overview of University of California, San Francisco 31
Duke University 32
Clinical Trial Overview of Duke University 32
Massachusetts General Hospital 33
Clinical Trial Overview of Massachusetts General Hospital 33
Children's Oncology Group 34
Clinical Trial Overview of Children's Oncology Group 34
The Hospital for Sick Children 35
Clinical Trial Overview of The Hospital for Sick Children 35
Radiation Therapy Oncology Group 36
Clinical Trial Overview of Radiation Therapy Oncology Group 36
Sun Yat-sen University 37
Clinical Trial Overview of Sun Yat-sen University 37
Societe Internationale d'Oncologie Pediatrique 38
Clinical Trial Overview of Societe Internationale d'Oncologie Pediatrique 38
Five Key Clinical Profiles 39
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 74

List of Tables
Low-Grade Glioma Therapeutics, Global, Clinical Trials by Region, 2014* 6
Low-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Low-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Low-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Low-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Low-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Low-Grade Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Low-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Low-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Low-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Low-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Low-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Low-Grade Glioma Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Low-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Low-Grade Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Low-Grade Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Low-Grade Glioma Therapeutics, Global, Suspended Clinical Trials, 2014* 22
Low-Grade Glioma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 22
Low-Grade Glioma Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Low-Grade Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Low-Grade Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Low-Grade Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Low-Grade Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Low-Grade Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Low-Grade Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stemline Therapeutics, Inc., 2014* 28
Low-Grade Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by AROG Pharmaceuticals LLC, 2014* 29
Low-Grade Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 30
Low-Grade Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 31
Low-Grade Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 32
Low-Grade Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 33
Low-Grade Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 34
Low-Grade Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2014* 35
Low-Grade Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014* 36
Low-Grade Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 37
Low-Grade Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Societe Internationale d'Oncologie Pediatrique, 2014* 38

List of Figures
Low-Grade Glioma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Low-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Low-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Low-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Low-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Low-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Low-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Low-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Low-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Low-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Low-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Low-Grade Glioma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Low-Grade Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Low-Grade Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Low-Grade Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Low-Grade Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Low-Grade Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Low-Grade Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Low-Grade Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.